UPDATE: Oppenheimer Downgrades Body Central Corp. (BODY) to Perform; Second Downward Revision Moves Us To Sidelines
Tweet Send to a FriendGet Alerts BODY Hot Sheet
Price: $12.14 +1.08%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade BODY Now!
(Updated - June 19, 2012 10:47 AM EDT)
Oppenheimer downgraded Body Central Corp. (NASDAQ: BODY) from Outperform to Perform.
Analyst, Pamela Quintiliano, said, "BODY downwardly revised guidance for the second time in as many months (recall on May 3rd first took down in conjunction with 1Q report). Unfortunately since then June-to-date has experienced a broad-based deceleration resulting in above-plan markdowns and significant gross margin pressure. Issues are not expected to be resolved until mid-3Q at the earliest. As such, prefer to take a wait-and-see approach..."
Oppenheimer lowers FY12 EOS estimate from $1.38 to $1.07 and FY13 from $1.70 to $1.40.
For an analyst ratings summary and ratings history on Body Central Corp. click here. For more ratings news on Body Central Corp. click here.
Shares of Body Central Corp. closed at $8.22 yesterday, with a 52 week range of $8.07-$30.93.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Oppenheimer downgraded Body Central Corp. (NASDAQ: BODY) from Outperform to Perform.
Analyst, Pamela Quintiliano, said, "BODY downwardly revised guidance for the second time in as many months (recall on May 3rd first took down in conjunction with 1Q report). Unfortunately since then June-to-date has experienced a broad-based deceleration resulting in above-plan markdowns and significant gross margin pressure. Issues are not expected to be resolved until mid-3Q at the earliest. As such, prefer to take a wait-and-see approach..."
Oppenheimer lowers FY12 EOS estimate from $1.38 to $1.07 and FY13 from $1.70 to $1.40.
For an analyst ratings summary and ratings history on Body Central Corp. click here. For more ratings news on Body Central Corp. click here.
Shares of Body Central Corp. closed at $8.22 yesterday, with a 52 week range of $8.07-$30.93.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Needham & Company Boosts Numbers on Infoblox (BLOX) on Strong Q3
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
